Given that lymph node metastasis directly affects the prognosis of patients with breast cancer [4], we propose that SDF-1, via the CXCR4 pathway, is potentially a marker of nodal involvement. Here, CXCR4 is linked to metastatic malignant neoplasm in the lymph nodes.